A new study found extensive alternative splicing of messenger RNA in the blood cells of untreated multiple sclerosis patients compared to healthy controls. The study, which showed that highly dysregulated alternative splicing was largely corrected by interferon-ß (IFN-ß) therapy, is published in the Journal of Interferon & Cytokine Research.
Research shows interferon-beta regulates excessive alternative splicing in multiple sclerosis
